コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 ated gene products were identified including ubiquitin C.
3 evealed transcriptional alterations of Creb, ubiquitin-C, and other housekeeping genes in PS-deficien
6 ays provide evidence that PPARbeta regulates ubiquitin C expression, and that ubiquitination of prote
9 the assertion that the homogenization of the ubiquitin-C gene in rodents is due to unequal crossing-o
13 ssing transgenic mice by inserting the human ubiquitin C promoter coupled to the firefly luciferase r
15 ouse transgenic line was generated using the ubiquitin C promoter to drive inducible expression of La
16 FP with the EF1 alpha promoter, pUB-GFP with Ubiquitin C promoter, and pEYFP-Mitotrap with CMV promot
17 nic fibroblasts, adenoviruses containing the ubiquitin C promoter, but not the cytomegalovirus immedi
18 ovirus immediate-early promoter, but not the ubiquitin C promoter, cooperated with chemotherapeutic a
21 virus encoded the GFP regulated by the human ubiquitin-C promoter, which is active in a wide variety
23 biquitinating enzymes based on the substrate ubiquitin C-terminal 7-amido-4-methylcoumarin (Ub-AMC).
25 (2) The kinetics of inhibition of UCH-L3 by ubiquitin C-terminal aldehyde (Ub-H) were determined and
26 omal protein synthesized as an 80-amino acid ubiquitin C-terminal extension protein (CEP80), function
27 allenge, we developed novel chemical probes, ubiquitin C-terminal fluorescein thioesters UbMES and Ub
28 ecies contain modified peptides in which the ubiquitin C-terminal Gly-Gly residues are retained on th
29 lement-binding protein 1 (CREB1), CREB2, and ubiquitin C-terminal hydrolase (Ap-uch) have been implic
32 e approach to tag active DUBs, we identified ubiquitin C-terminal hydrolase (UCH) isoform L3 as the p
34 esent study measured serum concentrations of ubiquitin C-terminal hydrolase (UCH-L1) and glial fibril
35 Glial Fibrillary Acidic Protein (GFAP) and Ubiquitin C-terminal hydrolase (UCH-L1) have been FDA-ap
36 f glial fibrillary acidic protein (GFAP) and ubiquitin C-terminal hydrolase (UCH-L1) levels became th
38 e crystal structure of the recombinant human Ubiquitin C-terminal Hydrolase (UCH-L3) by X-ray crystal
42 form a protein complex with the unidentified ubiquitin C-terminal hydrolase and recruit UbC1 to this
43 smodium falciparum homologue, members of the ubiquitin C-terminal hydrolase family, use a unique acti
45 the unfolded state of the 52-knotted protein ubiquitin C-terminal hydrolase isoenzyme L1 (UCH-L1) and
46 f glial fibrillary acidic protein (GFAP) and ubiquitin C-terminal hydrolase L1 (UCH-L1) as day-of-inj
47 Glial fibrillary acidic protein (GFAP) and ubiquitin C-terminal hydrolase L1 (UCH-L1) have been wid
50 ifunctional molecule of the ubiquitin system ubiquitin C-terminal hydrolase L1 (UCH-L1) is induced in
53 key mechanism mediating the deficit involves ubiquitin C-terminal hydrolase L1 (UCH-L1), a deubiquiti
54 h harbor a deletion within the gene encoding ubiquitin C-terminal hydrolase L1 (Uch-L1), display sens
55 We now show that a component of the pathway, ubiquitin C-terminal hydrolase L1 (Uch-L1), is required
57 cantly increase the levels of Abeta, Tau and Ubiquitin C-Terminal Hydrolase L1 (UCHL1) in mouse cereb
59 al fibrillary acidic protein (GFAP), tau and ubiquitin c-terminal hydrolase L1 (UCHL1) were assessed
61 amyloid-beta 1-42, neuropeptide Y (NPY), and ubiquitin C-terminal hydrolase L1 (UCHL1), whose CSF lev
62 ic enolase, glial fibrillary acidic protein, ubiquitin C-terminal hydrolase L1 [UCH-L1], neurofilamen
63 3% decrease; annexin VII, 8.8-fold increase; ubiquitin C-terminal hydrolase L1, 2.5-fold increase; AI
64 the ubiquitin-proteasome system, parkin and ubiquitin C-terminal hydrolase L1, are also associated w
65 associated with neurodegenerative diseases (ubiquitin C-terminal hydrolase L1, rat ortholog of human
67 in (KIAA0603), a novel protein AK000009, the ubiquitin C-terminal hydrolase L3 (UCHL3) and an F-box/P
72 report a novel interaction between Smads and ubiquitin C-terminal hydrolase UCH37, a deubiquitinating
73 members (USP4, USP15, USP11, and USP2), the ubiquitin C-terminal hydrolase UCHL3, and the Machado-Jo
74 d of K48 linkages, the proteasome-associated ubiquitin C-terminal hydrolase UCHL5/UCH37 serves as a p
77 lues, 0.34; 95% CI, 0.18-0.50; P < .001) and ubiquitin C-terminal hydrolase-L1 (mean difference in ln
78 f Glial Fibrillary Acidic Protein (GFAP) and Ubiquitin C-Terminal Hydrolase-L1 (UCH-L1) in a cohort o
82 lenged by the linkage of the neuronal enzyme ubiquitin C-terminal hydrolase-L1 (UCH-L1) to Parkinson'
84 asma glial fibrillary acidic protein (GFAP), ubiquitin C-terminal hydrolase-L1 (UCH-L1), neurofilamen
85 asma glial fibrillary acidic protein (GFAP), ubiquitin c-terminal hydrolase-L1 (UCH-L1), neurofilamen
89 ed included glial fibrillary acidic protein, ubiquitin C-terminal hydrolase-L1, neurofilament light c
100 quence of UCH-L1 is similar to that of other ubiquitin C-terminal hydrolases, including the ubiquitou
105 in-ROS protein conjugates; and (iv) distinct ubiquitin C-terminal isopeptidase/hydrolase activities,
106 t peptide ubiquitination probes based on the ubiquitin C-terminal scaffold can be developed through a
110 ted signaling pathway, where the exposure of ubiquitin C termini within protein aggregates enables HD
113 ly relevant and whether modifications of the ubiquitin C-terminus can modulate CXCR4 activation.
116 ragments is a 1.2-kb sequence from the human ubiquitin C (UBC) gene, encompassing the promoter, some